Hospital News
Return to Stomach Disease Overview
More on Stomach Disease
- Largest U.S. Hepatitis C Trial Provides Insight Into Optimizing Treatment for Patients
- $4 Million Gift Helps Create New Center for Inflammatory Bowel Disease at NewYork-Presbyterian/Weill Cornell
- Children's Hospital Appoints Foremost Authority on Treatment of Pediatric Liver and Bowel Disease
- Decades-Long Study Will Help Improve Surgery for Crohn's Disease
- Diabetes Surgery Program Opens at NewYork-Presbyterian/Weill Cornell
- Dr. Louis Aronne Named President of the North American Association for the Study of Obesity (NAASO)
- Dr. Timothy Wang Named Chief of Gastroenterology at NewYork-Presbyterian/Columbia and Silberberg Professor of Medicine at Columbia University College of Physicians and Surgeons
- Dr. William B. Inabnet Named Chief of Endocrine Surgery at NewYork-Presbyterian Hospital/Columbia University Medical Center
- Duodenal Switch May Be More Effective Than Gastric Bypass, NewYork-Presbyterian/Weill Cornell Study Finds
- Eltrombopag Effective for Hepatitis C Patients With Low Blood-Platelet Counts
- Futuristic Surgical Suites Open at NewYork-Presbyterian
- Gall Bladder Removed Vaginally Using Endoscope With Minimal External Incisions
- New Combined Laparoscopy and Colonoscopy Procedure May Avoid Need for Major Surgery
- New Comprehensive Gastrointestinal Health Center To Be Established at NewYork-Presbyterian Weill Cornell
- NewYork-Presbyterian Receives Highest Accreditation for Bariatric Surgery
- NYC Area's First Patient Receives New Incision-Free Weight-Loss Surgery at NewYork-Presbyterian/Columbia
- Responding to Obesity Epidemic, New Adolescent Bariatric Surgery Center Opens at Morgan Stanley Children's Hospital of NewYork-Presbyterian
- Review Outlines Risks and Benefits of Body Contouring for Massive Weight Loss After Bariatric Surgery
- Small, Open-Label Study Shows Potential Use of Novel Antibiotic Rifaximin for Crohn's Disease
- Surgeons Who Helped Pioneer Revolutionary Technique Present International Course on NOTES Surgery
- Type 2 Diabetes May Be Caused by Intestinal Dysfunction
- Want a Healthy Colon? Eat a Rainbow!
- Weill Cornell Scientists Identify Mechanism Governing Immune System Suppression
Health Library
Return to Stomach Disease Overview
More on Stomach Disease
- Alcohol-Induced Liver Disease
- Anal Cancer
- Barium X-Rays (Upper and Lower GI)
- Celiac Disease
- Cholangitis
- Cholecystitis
- Chronic Liver Disease / Cirrhosis
- Common Liver Function Tests
- Crohn's Disease
- Digestive Disorder Diagnostic Procedures
- Digestive System and Medications
- Digestive System Overview
- Gastritis
- Gastroesophageal Reflux Disease (GERD) / Heartburn
- Gastrointestinal Cancers
- Gastroparesis
- Giardiasis
- Helicobacter Pylori
- Hemolytic Uremic Syndrome
- Hepatitis, Drug-Induced
- Hepatitis A
- Hepatitis B
- Indigestion
- Irritable Bowel Syndrome (IBS)
- Lactose Intolerance: Diet
- Liver Disease: Statistics
- Liver Disorders
- Pancreatitis
- Peritonitis
- Pseudocysts of the Pancreas
- Stomach and Duodenal Ulcers (Peptic Ulcers)
- Stomach Cancer
- Traveler's Diarrhea
- Ulcerative Colitis
Clinical Services
Return to Stomach Disease Overview
More on Stomach Disease
- Advanced Diagnostics
- Anorectal Disease
- Colon and Rectal Surgery
- Colorectal Disease
- Diabetes and Endocrinology
- Gastroenterology and Hepatology (Digestive Diseases)
- General Surgery
- Groundbreaking Therapeutics
- Liver Disease
- Minimal Access Surgery Center
- Prevention Programs
- Preventive Medicine and Nutrition
- Stomach Cancer
Stomach Disease
In the area of gastric diseases and disorders, our physicians offer specialized expertise in abdominal malignancies, peptic ulcer disease, acid hypersecretory conditions, Zollinger-Ellison Syndrome, gastrointestinal (GI) bleeding, and obesity. Clinical trials are investigating new drugs to treat inflammatory bowel disease (IBD), irritable bowel syndrome, peptic ulcer disease, and GI bleeding, as well as probiotics to treat GI illnesses. Researchers also are investigating the molecular and cellular mechanisms of IBD and the role of serotonin in controlling bowel behavior in patients with the disease.
Contact
- Digestive and Liver Diseases, NewYork-Presbyterian/Columbia
-
Directions
(212) 305-8156
- Gastroenterology and Hepatology, NewYork-Presbyterian/Weill Cornell
-
Directions
(212) 746-4400
